Recently the korean healthcare industry has been growing rapidly due to ageing population and its ever-growing concern about well-being. The global competitiveness of korean medical device industry is however relatively mediocre compared to that of other domestic industries. To remedy such an undesirable situation, the korean government has supported, since 2010, the project of establishing intermediator platforms which collect viable ideas from the medical care providers, develop working mock-ups or prototypes from these ideas and license these technologies out to the manufacturers who want to commercialize them. The purpose of this study is to analyze the risks which can cause the failure of such an open-innovation-based idea realization platform and derive some useful guidelines for their effective management. More precisely, we analyze the objectives of the platform, identify typical sources of failure that make the fulfillment of these objectives difficult, and select and evaluate major risk factors which contribute to each failure source. The analysis is based on the results of the structured interview with the supervising director of the idea realization center, the one first started in 2010, and the results of the questionnaire survey conducted on the experts who participated in several parts of the idea realization process in that organization. The results show that 'a weak network among idea sources' and 'an inappropriate compensation system for realized ideas' are the most important risk factors, together with 'an insufficient development capacity' and 'the risk of failure to find interested buyers for the secured technology rights'. Thorough understanding of those risk factors and appropriate decisions on the response measures, and their continuous monitoring, would be essential part of risk management for an open-innovation-based medical device idea realization platform. †
. Chesbrough(2003 Chesbrough( , 2006 (Huizingh, 2011) . 이를 위해 중계자(intermediator)를 통해 개방형 혁신을 추진하는 방법이 제안되었다. Lee et al.(2010) The risk of collecting small number of ideas because the active PR(public relation) efforts to inform people about the platform are not sufficient so that the potential idea-providers are unaware of the existence of the platform or of the benefits it offers.
R12 Weak Network among Idea Sources
The risk of collecting small number of ideas because there exist no systematic networks between the platform and the organizations such as hospitals, research institutes or universities which have some potential to provide for good ideas and share the benefits.
R13 Inadequate Idea Compensation System
The risk of collecting small number of ideas because the potential idea providers are not satisfied with the compensations they would get in case they offer their ideas to the platform.
Inaccurate Screening and Selection of Ideas

R21
Inadequate Idea Evaluation and Selection System
The risk of selecting ideas which should have been rejected, or rejecting ideas which should have been selected, just because the system and the process to evaluate and select the ideas are not properly designed to fit the purpose of the platform
R22
Difficulties in Procuring Competent
Idea Evaluators
The risk of idea evaluation/selection error rate being unacceptably high because it is difficult to procure competent evaluators who have sufficient technical capabilities and related experiences to judge the level of technical difficulties and/or the marketability of submitted ideas.
R23 Inadequate Compensation System for Idea Evaluators
The risk of idea evaluation/selection error rate being unacceptably high because the compensation system for the evaluators cannot induce sufficient motivations for them to evaluate the ideas carefully and correctly.
Difficulties in Mock-up Development
R31
Insufficient Internal Development Capacity
The risk of development success rate being excessively low because the internal resources to be assigned to the idea realization process are not sufficiently secured and/or lack the needed technical proficiency and experiences.
R32
Difficulties in Procuring Competent External Developers
The risk of development success rate being excessively low because it is difficult to procure externally developers who possess sufficient development capacity to realize the ideas as working mock-ups with reasonable costs.
R33 Insurmountable Technology Barriers
The risk of many of the mock-up development projects resulting in failure because some unexpected technical difficulties occur during the project and these are not resolvable within reasonable time and cost constraints.
R34
Ineffective Management of Development Project
The risk of project management being a failure because, in most of the projects, unacceptably excessive time and cost are needed to complete the development of working mock-up or the desired performance requirements are not fully satisfied.
R41 Insufficient Number of Patent Application
The risk of the number of patent applications being too low because most of the realized working mock-ups and the developed technologies are not worthy of being applied to domestic or foreign patents. Difficulties in Patent Acquisition R42 Low Success Rate of Patent Acquisition
The risk of the success rate of patent acquisition being too low because novelty and value of the most of the technologies applied for patents are not properly assessed prior to the applications.
Insufficient Revenue from
Technology Transfer
R51
Difficulties in Finding Adequate Technology Buyer
The risk of being unable to recover most of the development costs because of the difficulties to find appropriate medical device manufacturers or investors who would want to license the secured technology and develop them as marketable products.
R52 Inappropriate Valuation of Technology
The risk of being unable to recover most of the development costs because the greater part of secured technology rights are undervalued and consequently the negotiations for licensing are concluded unfavorably. 
